Press Releases Galapagos NV Nasdaq

Equities

GLPG

US36315X1019

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
28.76 ^USD	+0.45%		-1.10%	-29.25%

Apr. 08	Galapagos Showcases Innovative Approach in Hematological Cancer Care with Clinical and Translational Data Presentations at EBMT Congress 2024	CI
Mar. 28	Galapagos Continues to be 'Value Trap' With Unclear Growth Path, BofA Says	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Galapagos : Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024	Apr. 05	PU
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024	Apr. 04	GL
Galapagos : Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings	Mar. 29	PU
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings	Mar. 28	GL
Galapagos : Galapagos benoemt Andrew Dickinson tot Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder van haar Raad van Bestuur	Mar. 27	PU
Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its Board	Mar. 26	GL
Galapagos announces full year 2023 results and outlook for 2024	Feb. 22	GL
Galapagos presents at EBMT-EHA annual meeting 2024	Feb. 15	GL
Galapagos presents at EBMT-EHA annual meeting 2024	Feb. 15	AQ
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma	Jan. 31	GL
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.	Jan. 04	GL
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.	Jan. 04	AQ
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology	Jan. 03	GL
Galapagos signs agreement to transfer Jyseleca business to Alfasigma	Jan. 03	AQ
Galapagos : Galapagos signs agreement to transfer Jyseleca® business to Alfasigma	Jan. 02	PU
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma	Jan. 02	GL
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma	Jan. 02	AQ
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301	Dec. 19	GL
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301	Dec. 19	AQ
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101	Dec. 09	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Galapagos NV Nasdaq

Equities

GLPG

US36315X1019

Press Releases

Filters